An approved diabetes drug may change the progression of Parkinson's disease rather than just treating symptoms while the disease worsens.
Feinstein Institute-led researchers used an Alzheimer’s drug to reduce inflammation in people with metabolic syndrome.
For pharma and biotech, in which data is the most valuable asset, industry analysts agree that digital transformation presents an opportunity to realize…
Targeting a cell process that promotes protein clumping could lead to new drugs for ALS.
A pair of experimental vaccines protected mouse fetuses from brain defects caused by Zika infection.
Anti-CRISPR proteins may be the key to preventing harmful side effects from off-target editing.
Researchers at Washington University have discovered a new way to shield fetuses from Zika using a common and inexpensive malaria drug.
A team led by Washington University in St. Louis has unraveled the structure of a protein that allows RSV to elude the immune system.
A new finding by scientists at NYU may prompt fresh ideas for reversing the buildup of plaque in arteries.
A University of Cambridge team used computer-designed antibodies to stop amyloid-beta plaques, a hallmark of Alzheimer's disease, from forming.
For the first time, Stanford University researchers have used a new type of whole-genome sequencing to diagnose a patient.